TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nec Oncoimmunity AS
Closing information (x1000 NOK)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
40,562
|
45,052
|
3,223 |
| Financial expenses |
1,509
|
2,239
|
2,403 |
| Earnings before taxes |
-67,893
|
-44,999
|
-36,394 |
| Total assets |
73,048
|
87,807
|
73,046 |
| Current assets |
67,349
|
81,710
|
65,300 |
| Current liabilities |
28,804
|
42,146
|
12,386 |
| Equity capital |
44,244
|
45,660
|
60,660 |
| - share capital |
388
|
372
|
352 |
| Employees (average) | 18 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
60.6%
|
52.0%
|
83.0% |
| Turnover per employee | 179 | ||
| Profit as a percentage of turnover |
-167.4%
|
-99.9%
|
-1129.2% |
| Return on assets (ROA) |
-90.9%
|
-48.7%
|
-46.5% |
| Current ratio |
233.8%
|
193.9%
|
527.2% |
| Return on equity (ROE) |
-153.5%
|
-98.6%
|
-60.0% |
| Change turnover |
-4,490
|
41,829
|
836 |
| Change turnover % |
-10%
|
1298%
|
35% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.